Kelvin K C Sham

Title: The Innovative Contributions of Kelvin K C Sham

Introduction

Kelvin K C Sham is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of 10 patents to his name, Sham's work has the potential to impact the treatment of several serious health conditions.

Latest Patents

Sham's latest patents include "Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors" and "Triazole fused heteroaryl compounds and methods of use thereof." The first patent focuses on compounds that inhibit PDE10, which can be used to treat disorders such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, and obsessive-compulsive disorder. The second patent introduces a new class of compounds that modulate the activity of p38 MAP kinase, which is relevant for treating diseases like rheumatoid arthritis, psoriasis, and other inflammatory disorders.

Career Highlights

Throughout his career, Kelvin K C Sham has been associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to explore innovative solutions in drug development and contribute to advancements in medical science.

Collaborations

Sham has collaborated with notable colleagues, including Dawei Zhang and Andrew Stewart Tasker. These collaborations have fostered a productive environment for research and innovation, leading to the development of impactful pharmaceutical compounds.

Conclusion

Kelvin K C Sham's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new treatments that address critical health issues.